For treatment and management of epilepsy and anxiety disorder.
Clobazam binds at a distinct binding site associated with a Cl<sup>-</sup> ionopore at the GABA-A receptor, increasing the duration of time for which the Cl<sup>-</sup> ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is prolonged as a result.
Bioavailability is 90%.
18 hours